AI Article Synopsis

  • The study aimed to evaluate the impact of 20(S)-ginsenoside Rh2 on HepG2 liver cancer cells and xenograft tumors, focusing on the mechanisms involved.
  • Results indicated that Rh2 treatment decreased HDAC activity and increased HAT activity, which contributed to alterations in cell cycle distribution and apoptosis in HepG2 cells.
  • Additionally, Rh2 influenced gene expression related to cell proliferation and inflammation, demonstrating its potential as a therapeutic agent for liver cancer.

Article Abstract

Purpose: To investigate the effect of 20(S)-ginsenoside Rh2 (Rh2) on anti HepG2 liver cancer cells and HepG2 cell-derived xenograft tumors, and explore the underlying mechanisms.

Materials And Methods: The activity of total HDACs and HAT were assessed with a HDACs colorimetric kit. Expression of HDAC1, HDAC2, HDAC6, p-ERK, ERK, p-P38, P38, p-JNK and JNK proteins was tested by Western blotting.H3K9 and H3K14 proteins were also checked by immunofluorescence, changes in cell cycle distribution with flow cytometry, cell apoptosis with annexin V-FTIC/PI double staining. Activity of Renilla luciferase (HIF) was detected using the Luciferase Reporter Assay system reagent. Gene expression for CyclinD1, Bcl-2, Bax, HIF, IL-1, IL-6, IL-10 and TNF-α was tested by q-PCR. Expression levels of CD31 and Ki-67 was tested by immunohistochemical staining.

Results: Total HDAC activity was decreased and total histone acetyltransferase (HAT)activity was increased in a time-dependent manner. Expression of HDAC1 and p-JNK proteins was significantly increased, expression levels of p-ERK was decreased. H3K9 and H3K14 fluorescence protein were increased. Flow cytometric analysis of the cell cycle revealed that the percentage of cells in the G0/G1 phase in the treatment group(64.35±1.36%) was significantly increased compared with the untreated group(61.61±1.23%).The apoptotic rate of the HepG2 group was 10.03±1.92%, which increased to 17.87±1.67% in the treatment group. Expression levels of the transcription factor HIF were also increased in HepG2 cells following induction by Rh2. Expression of CyclinD1 and Bcl-2 at the genetic level was significantly decreased, while expression levels of Bax, HIF, IL-1, IL-6, IL-10 and TNF-α was increased. In vivo, the expression levels of both CD31 and Ki-67 proteins were significantly down-regulated in the treatment group compared with the control group.

Conclusions: The effects of Rh2 were suggested to occur through the inhibition of total HDAC activity, which subsequently induced MAPK signaling and down-regulated the expression of HIF.
.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629470PMC
http://dx.doi.org/10.31557/APJCP.2021.22.8.2529DOI Listing

Publication Analysis

Top Keywords

expression levels
20
expression
10
hepg2 cells
8
cells hepg2
8
hepg2 cell-derived
8
cell-derived xenograft
8
xenograft tumors
8
mapk signaling
8
expression hdac1
8
cell cycle
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!